Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Citi
McKesson
Julphar
Covington
Farmers Insurance
Healthtrust
Federal Trade Commission
Harvard Business School
Teva

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,767,901

« Back to Dashboard

Which drugs does patent 6,767,901 protect, and when does it expire?

Patent 6,767,901 protects OMNARIS and is included in one NDA.

This patent has forty-four patent family members in thirty-five countries.
Summary for Patent: 6,767,901
Title: Ciclesonide contained pharmaceutical composition for application to mucosa
Abstract:The present invention provides a pharmaceutical composition for application to the mucosa to be used in drug therapy comprising a water-insoluble and/or water-low soluble substance, ciclesonide, and an aqueous medium, and having an osmotic pressure of less than 290 mOsm. This composition is superior over conventional pharmaceutical compositions for application to the mucosa, due to efficient and high ciclesonide retentivity and permeability to the submucosa or the blood at the mucosa.
Inventor(s): Nagano; Atsuhiro (Tokyo, JP), Nishibe; Yoshihisa (Yamaguchi, JP), Takanashi; Kazuya (Tokyo, JP)
Assignee: Altana Pharma AG (Constance, DE)
Application Number:10/110,629
Patent Claim Types:
see list of patent claims
Composition;

Drugs Protected by US Patent 6,767,901

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Astrazeneca Pharms OMNARIS ciclesonide SPRAY, METERED;NASAL 022004-001 Oct 20, 2006 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,767,901

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan11-298185Oct 20, 1999
PCT Information
PCT FiledOctober 20, 2000PCT Application Number:PCT/JP00/07350
PCT Publication Date:April 26, 2001PCT Publication Number: WO01/28562

International Patents Family Members for US Patent 6,767,901

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 026072 ➤ Sign Up
Austria 285779 ➤ Sign Up
Australia 781895 ➤ Sign Up
Australia 7953100 ➤ Sign Up
Bulgaria 106512 ➤ Sign Up
Bulgaria 65818 ➤ Sign Up
Brazil 0014878 ➤ Sign Up
Brazil PI0014878 ➤ Sign Up
Canada 2388322 ➤ Sign Up
China 101869570 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Daiichi Sankyo
Citi
UBS
Teva
Cipla
Chinese Patent Office
Cantor Fitzgerald
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot